EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 10th, 2019 • Monopar Therapeutics • Pharmaceutical preparations • Illinois
This Executive Employment Agreement (the “Agreement”) is entered into as of November 1, 2017, by and between Kim R. Tsuchimoto (“Executive”) and Monopar Therapeutics Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 10th, 2019 • Monopar Therapeutics • Pharmaceutical preparations • Illinois
This Executive Employment Agreement (the "Agreement") is entered into as of November 1, 2017, by and between Andrew P. Mazar ("Executive") and Monopar Therapeutics Inc. (the "Company").
CONTRIBUTION AGREEMENT (351)Contribution Agreement • September 10th, 2019 • Monopar Therapeutics • Pharmaceutical preparations • Delaware
This Contribution Agreement (this “Agreement”) is entered into as of August 25, 2017 (the “Effective Date”), among TacticGem LLC, a Delaware limited liability company (the “Company”), Monopar Therapeutics Inc., a Delaware corporation (“Monopar”), Gem Pharmaceuticals, LLC, an Alabama limited liability company (“Gem”) and Tactic Pharma, LLC, an Illinois limited liability company (“Tactic”, and collectively with Gem, the owners of 100% of the issued and outstanding limited liability company interests of the Company). The Company, Monopar, Tactic, and Gem are sometimes hereinafter referred to collectively as the “Parties”, and each individually as a “Party”.
